Christophe Sauzet
Overview
Explore the profile of Christophe Sauzet including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
28
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lamy E, Orneto C, Ali O, Kireche L, Mathias F, Bouguergour C, et al.
Pharmaceuticals (Basel)
. 2025 Feb;
18(2).
PMID: 40006018
Little information is available on the stability and quality controls of compounded 40% dextrose gel required to ensure its safe use in the treatment and prevention of neonatal hypoglycemia. Whether...
2.
May P, Bremond P, Sauzet C, Piccerelle P, Grimaldi F, Champion S, et al.
Int J Mol Sci
. 2018 Mar;
19(3).
PMID: 29534036
(1) Objective: Highlight the in vitro effects of 3T3-L1 cell exposure to polychlorinated biphenyls (PCB118 and 153) or benzo(a)pyrene (BaP) alone or as a cocktail on adipogenesis (ADG) by focusing...
3.
Bennis Y, Savry A, Correard F, Montana M, Sauzet C, Gauthier-Villano L, et al.
Int J Pharm
. 2015 Oct;
495(2):956-62.
PMID: 26453779
Introduction: Epirubicin is widely used for conventional transcatheter arterial chemoembolization (cTACE) in patients with hepatocellular-carcinoma. However, there is no data about its stability in solution at concentration higher than 2...
4.
Mesnier A, Champion S, Louis L, Sauzet C, May P, Portugal H, et al.
PLoS One
. 2015 Jun;
10(6):e0128847.
PMID: 26086818
Epidemiological studies have associated environmental exposure to polychlorinated biphenyls (PCBs) with an increased risk of type 2 diabetes; however, little is known about the underlying mechanisms involved in the metabolic...
5.
Prinderre P, Sauzet C, Fuxen C
Expert Opin Drug Deliv
. 2011 Jun;
8(9):1189-203.
PMID: 21671821
Introduction: In recent years, various technological improvements have been achieved and new concepts have been developed, in the area of controlled release solid oral dosage forms, especially for products where...